xMD-miRNA-Seq estimates cell-specific miRNA expression
xMD-miRNA-Seq 估计细胞特异性 miRNA 表达
基本信息
- 批准号:10240467
- 负责人:
- 金额:$ 31.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAntigensArchivesAtlasesBasic ScienceBiological MarkersBiologyCancer BiologyCardiovascular DiseasesCardiovascular systemCellsChemicalsCollectionColonColorComplementCultured CellsDataDevelopmentDiseaseDoctor of PhilosophyEndothelial CellsEpithelialEpithelial CellsEthylenesFibroblastsFormalinGenerationsGenesGlassGlomerular capsule structureGoalsHealthHigh temperature of physical objectHumanHuman ResourcesImmunohistochemistryImmunologyKidneyKnowledgeLeadLiftingLightMembraneMethodologyMethodsMicroRNAsMicrodissectionModificationNormal tissue morphologyParaffin EmbeddingPathologistPhenotypePigmentsPreparationProcessProtocols documentationRNARNA FoldingRNA libraryReagentResearchResearch PersonnelResourcesRetrievalRibonucleasesRibosomal RNARibosomesRoleRunningSequence AlignmentSlideSmall RNASourceSpecimenSurfaceSurgical PathologyTechniquesTechnologyTemperatureTherapeuticTimeTissue EmbeddingTissuesWorkanimal tissuebasecell typecost effectivedesignglomerular endotheliumhigh throughput technologyhuman diseasehuman tissueimprovedin vivoinhibitor/antagonistinterestlaser capture microdissectionlight intensitymeltingmesangial cellmiRNA expression profilingnervous system disordernew technologypodocyteresearch studysuccesstechnology developmenttooltranscriptome sequencingvinyl acetate
项目摘要
Project Summary/Abstract
There has been an important realization over the past several years that in order to truly understand
human disease we must understand not just the diseased tissues, but rather the cells in those tissues. To that
end, we need tools that can capture those cells and explore their expression profiles. We have developed a
technology called xMD-miRNA-Seq to do just that. The xMD stands for expression microdissection and it
allows us to collect one cell type at a time from any fixed tissue source. We have developed a way to use
those cells for small RNA sequencing to capture the expression profile of microRNAs from just these cells.
microRNAs (miRNAs) are small, regulatory RNAs involved in disease and development. Although this is an
exciting, powerful technique designed to help understand cell expression, it remains relatively inefficient.
Therefore, we have proposed a set of optimizations to make the technique widely adaptable.
We have proposed to optimize the capture of cells moving from a slide to an affixed membrane by
adjusting features including the temperature, the light intensity, the background type and even the membrane
itself. We also seek to limit the loss of RNA through the steps of the xMD process by pretreating certain
reagents with chemicals designed to remove RNAses. Finally, we will work with both established and new
methods to maximize the percent of miRNAs that are read in a small RNA sequencing run. Ultimately, these
modifications will greatly enhance the value of the xMD-miRNA-seq method and will allow us to obtain the
miRNA profile of almost any human cell type in almost any disease setting. This will be important for cancer
biology, immunology, development, cardiovascular disease, neurologic disorders and many other settings.
项目总结/摘要
在过去的几年里,有一个重要的认识,为了真正了解
我们不仅要了解患病的组织,还要了解这些组织中的细胞。与
最后,我们需要能够捕获这些细胞并探索其表达谱的工具。我们已经开发出一种
一种叫做xMD-miRNA-Seq的技术来做到这一点。xMD代表表达显微切割,
允许我们从任何固定的组织来源一次收集一种细胞类型。我们发明了一种方法
这些细胞进行小RNA测序,以捕获来自这些细胞的microRNA的表达谱。
microRNA(miRNAs)是一种小的调控RNA,参与疾病和发育。虽然这是一个
虽然这项技术是一项令人兴奋的、强大的技术,旨在帮助理解细胞表达,但它仍然相对低效。
因此,我们提出了一组优化,使该技术具有广泛的适应性。
我们已经提出通过以下方式来优化从载玻片移动到固定膜的细胞的捕获:
调节功能,包括温度,光强度,背景类型,甚至膜
本身我们还试图通过预处理某些RNA来限制通过xMD过程步骤的RNA损失。
含有去除核糖核酸酶的化学试剂。最后,我们将与既有和新的
最大化在小RNA测序运行中读取的miRNA百分比的方法。最终,这些
修改将大大提高xMD-miRNA-seq方法的价值,并使我们能够获得
几乎任何疾病背景下几乎任何人类细胞类型的miRNA谱。这对癌症很重要
生物学、免疫学、发育学、心血管疾病、神经系统疾病和许多其他环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC K HALUSHKA其他文献
MARC K HALUSHKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC K HALUSHKA', 18)}}的其他基金
xMD-miRNA-Seq estimates cell-specific miRNA expression
xMD-miRNA-Seq 估计细胞特异性 miRNA 表达
- 批准号:
10001551 - 财政年份:2018
- 资助金额:
$ 31.11万 - 项目类别:
xMD-miRNA-Seq estimates cell-specific miRNA expression
xMD-miRNA-Seq 估计细胞特异性 miRNA 表达
- 批准号:
9634161 - 财政年份:2018
- 资助金额:
$ 31.11万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 31.11万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 31.11万 - 项目类别: